Single-cell genomics company Parse Biosciences Inc. was hit with a patent infringement lawsuit Wednesday in Delaware District Court. The suit, filed by Morris, Nichols, Arsht & Tunnell; and Paul, Weiss, Rifkind, Wharton & Garrison on behalf of gene sequencing technology manufacturer 10X Genomics Inc., asserts six patents related to the methods for analyzing nucleic acids from single cells and evaluating chromatin accessibility within genomes at the single cell level. The case is 1:22-cv-01117, 10X Genomics, Inc. v. Parse Biosciences, Inc. et al.
Biotech & Pharmaceuticals
August 26, 2022, 6:05 AM